Genetic test could predict who benefits most from popular Weight-Loss drugs
NCT ID NCT06069622
Summary
This study aims to understand why people respond differently to GLP-1 weight loss medications like Wegovy or Ozempic. Researchers will test 30 overweight or obese adults to see if a specific gene variation affects how much their blood pressure drops and how much weight they lose on the drug. The goal is to help doctors personalize obesity treatment in the future.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVERWEIGHT AND OBESITY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Brigham and Women's Hospital
RECRUITINGBoston, Massachusetts, 02115, United States
Contact
Contact
Conditions
Explore the condition pages connected to this study.